Rogelio Domínguez-Moreno1, Miguel García-Grimshaw2, David Medina-Julio3, Carlos Cantú-Brito3, Alejandra González-Duarte3. 1. Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga #15, Col. Sección XVI Belisario Domínguez, 14080, Tlalpan, Mexico City, Mexico. rogelio_dm@hotmail.com. 2. Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga #15, Col. Sección XVI Belisario Domínguez, 14080, Tlalpan, Mexico City, Mexico. miguelgrimshaw@gmail.com. 3. Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga #15, Col. Sección XVI Belisario Domínguez, 14080, Tlalpan, Mexico City, Mexico.
Abstract
BACKGROUND: Tuberculous meningitis (TBM) is the most frequent, severe, and disabling form of central nervous system (CNS) tuberculosis (TB). TBM paradoxical manifestations are characterized by clinical or paraclinical worsening after 1 month of effective anti-TB treatment in patients who initially responded to treatment despite the use of adjunctive corticosteroids. METHODS: Retrospective descriptive study of consecutive HIV-negative adult patients (≥ 18 years) with definitive TBM who developed a paradoxical manifestation following anti-TB in a tertiary-care hospital in Mexico from 2009 to 2019; we also conducted a literature review of published cases/series of paradoxical manifestations in HIV-negative patients from 1980 to 2020. RESULTS: We detected 84 cases of definitive TBM; 55 (68.7%) HIV-negative patients and 29 (36.3%) HIV-infected patients. Among HIV-negative patients, four (7.3%), three female and one male (19-49 years old), developed a paradoxical manifestation within 4-14 weeks following treatment initiation despite receiving adequate corticosteroid doses; Mycobacterium bovis was isolated from the cerebrospinal fluid of three cases and Mycobacterium tuberculosis in one more. Two patients developed vasculopathy-related cerebral infarctions, one severe basilar meningitis, and hydrocephalus, one more a tuberculoma. Two were treated with intravenous cyclophosphamide, and two with steroids. One of the patients treated with steroids died; patients who received cyclophosphamide had a good clinical response. CONCLUSIONS: This case series illustrates the diverse clinical/radiologic paradoxical manifestations of TBM in HIV-negative patients. Cyclophosphamide may be safe and effective in treating TBM-associated paradoxical manifestations. Specific diagnostic and care protocols for these patients are needed.
BACKGROUND: Tuberculous meningitis (TBM) is the most frequent, severe, and disabling form of central nervous system (CNS) tuberculosis (TB). TBM paradoxical manifestations are characterized by clinical or paraclinical worsening after 1 month of effective anti-TB treatment in patients who initially responded to treatment despite the use of adjunctive corticosteroids. METHODS: Retrospective descriptive study of consecutive HIV-negative adult patients (≥ 18 years) with definitive TBM who developed a paradoxical manifestation following anti-TB in a tertiary-care hospital in Mexico from 2009 to 2019; we also conducted a literature review of published cases/series of paradoxical manifestations in HIV-negative patients from 1980 to 2020. RESULTS: We detected 84 cases of definitive TBM; 55 (68.7%) HIV-negative patients and 29 (36.3%) HIV-infected patients. Among HIV-negative patients, four (7.3%), three female and one male (19-49 years old), developed a paradoxical manifestation within 4-14 weeks following treatment initiation despite receiving adequate corticosteroid doses; Mycobacterium bovis was isolated from the cerebrospinal fluid of three cases and Mycobacterium tuberculosis in one more. Two patients developed vasculopathy-related cerebral infarctions, one severe basilar meningitis, and hydrocephalus, one more a tuberculoma. Two were treated with intravenous cyclophosphamide, and two with steroids. One of the patients treated with steroids died; patients who received cyclophosphamide had a good clinical response. CONCLUSIONS: This case series illustrates the diverse clinical/radiologic paradoxical manifestations of TBM in HIV-negative patients. Cyclophosphamide may be safe and effective in treating TBM-associated paradoxical manifestations. Specific diagnostic and care protocols for these patients are needed.
Authors: Robert J Wilkinson; Ursula Rohlwink; Usha Kant Misra; Reinout van Crevel; Nguyen Thi Hoang Mai; Kelly E Dooley; Maxine Caws; Anthony Figaji; Rada Savic; Regan Solomons; Guy E Thwaites Journal: Nat Rev Neurol Date: 2017-09-08 Impact factor: 42.937
Authors: Le Thi Phuong Thao; A Dorothee Heemskerk; Ronald B Geskus; Nguyen Thi Hoang Mai; Dang Thi Minh Ha; Tran Thi Hong Chau; Nguyen Hoan Phu; Nguyen Van Vinh Chau; Maxine Caws; Nguyen Huu Lan; Do Dang Anh Thu; Nguyen Thuy Thuong Thuong; Jeremy Day; Jeremy J Farrar; M Estee Torok; Nguyen Duc Bang; Guy E Thwaites; Marcel Wolbers Journal: Clin Infect Dis Date: 2018-02-01 Impact factor: 9.079
Authors: Miguel García-Grimshaw; Francisco Alejandro Gutiérrez-Manjarrez; Samuel Navarro-Álvarez; Alejandra González-Duarte Journal: J Epidemiol Glob Health Date: 2020-03
Authors: Andre Marolop Pangihutan Siahaan; Steven Tandean; Rr Suzy Indharty; Bahagia Willibrodus Maria Nainggolan; Martin Susanto Journal: Int J Surg Case Rep Date: 2022-09-08